Background: Chronic renal failure (CRF) is associated with hypertension, proteinuria, loss of myogenic constriction (MC) of mesenteric arteries and increased production of reactive oxygen species (ROS) under experimental conditions. Previous results showed that ACE (angiotensin-converting enzyme activity) inhibitor therapy is effective in slowing down the progression of disease. Therefore, we wanted to study whether the inverse AT 1 (angiotensin II type 1) receptor agonist, losartan (LOS) was effective in preventing loss of MC in a rat model of CRF and whether acute ROS scavengers could improve MC. Methods: Rats underwent 5/6 nephrectomy (5/6 Nx) and were treated with vehicle or LOS (20 mg/kg/day; 5/6 Nx + LOS) for 12 weeks. Thereafter, the MC of the mesenteric arteries were measured in the presence and/or absence of tempol and catalase. Systolic blood pressure and proteinuria were measured weekly. Results: Systolic blood pressure and proteinuria in the 5/6 Nx + LOS group were significantly lower than in the 5/6 Nx group. Moreover, the MC of 5/6 Nx + LOS arteries was significantly increased compared with the untreated 5/6 Nx group (maximum MC, 32.3 ± 6.9 vs 8.9 ± 3.8% (p < 0.01)). Tempol + catalase significantly increased the MC in the 5/6 Nx group, but not in the 5/6 Nx + LOS group (increase in MC, 59.7 ± 13.0 (p < 0.05) vs. 17.0 ± 15.1%). Conclusion: These results support the roles of the RAAS (renin-angiotensin-aldosterone system) and ROS in the vascular dysfunction of systemic vessels in CRF.
Introduction
Chronic kidney disease (CKD) is a worldwide health problem and is associated with an increased risk of cardiovascular disease and chronic renal failure (CRF). In both clinical and experimental conditions, proteinuria 1 and glomerulosclerosis 2 are hallmarks of CKD, leading to end organ failure. Pathological alterations of the vasculature, in both functional and structural ways, 3 vary in intensity depending on the progression of CKD. The ability of small arteries to constrict with elevated transmural pressure, termed myogenic constriction (MC), varies among different vascular beds and under different physiological 4 and/or pathological conditions. 5, 6 Myogenic constriction represents the main aspect of peripheral resistance, serves as an autoregulatory mechanism to protect organs from damage and maintains their constant blood supply. The exact mechanism of MC is not yet completely clarified, and several pathways have been suggested to be involved. 7, 8, 9 Several animal strains spontaneously develop disturbances in MC. Animal models of hypertension, such as the spontaneously hypertensive rat (SHR), for instance, develop excessive contractile responses in the renal 10 and peripheral vasculature, 11 contributing to elevated peripheral resistance and high systemic blood pressure. Furthermore, the fawn-hooded hypertensive (FHH) rat develops hypertension-associated renal damage as a result of an impairment in MC of the renal afferent vasculature, 12 while peripheral vascular beds do not display these alterations. 13 In the rat, the induction of organ damage such as chronic heart failure causes an increase in the myogenic response of the mesenteric arteries. In contrast, CRF induced by 5/6 nephrectomy (5/6 Nx) causes loss of myogenic response in the same arterial bed. In both cases, treatment with ACE inhibitors (ACE-i) reverses altered MC, implicating a role of the renin-angiotensin-aldosterone system (RAAS). [14] [15] [16] The metabolism of oxygen by vascular smooth muscle cells (VSMCs) generates potentially harmful reactive oxygen species (ROS), including superoxide anion and hydroxyl radicals, as well as hydrogen peroxide. Under normal physiological conditions, the extent and rate of oxidant formation is balanced by the rate of oxidant elimination by the antioxidant enzymatic system, involving such as superoxide dismutase (SOD) and catalase. SOD converts superoxide radicals to H 2 O 2 , which in turn is converted into water and oxygen by catalase. 17 However, the disturbed balance between ROS and antioxidants results in oxidative stress, which is the pathogenic substrate of vascular damage in various cardiovascular pathologies, including hypertension, endothelial dysfunction and atherosclerosis. 18, 19 Also, increased superoxide production contributes to reduced nitric oxide (NO) bioavailability, which results in endothelial dysfunction. Nevertheless, the pathways of MC are not yet fully elucidated and therefore the role of ROS in MC also remains uncertain.
Several experimental data indicate that increased oxidative stress contributes to hypertension in 5/6 Nx. 20, 21 Treatment with tempol, which has a catalytic role in superoxide dismutation 22 and thus performs a similar reaction to SOD, improves the aortic endothelial function 23, 24 of rats that had undergone 5/6 Nx. Nevertheless, the pathway by which ROS acutely or chronically contributes to the diminished myogenic response in 5/6 Nx is as yet unknown.
The aim of the present study was to investigate the chronic effect of the inverse AT 1 -receptor agonist losartan on changes in the MC of the small mesenteric arteries of rats with CRF induced by 5/6 Nx. Blood pressure and proteinuria was monitored weekly during the study. Twelve weeks after 5/6 Nx, the experiment was terminated and segments of the thirdorder branch of the mesenteric artery were examined to assess contractile response to pressure in a perfused vessel set-up. Moreover, to clarify the acute role of ROS in the diminished myogenic response of mesenteric arteries, a combination of tempol and catalase was applied to the organ bath, in order to achieve complete ROS degradation.
Materials and methods

Animals, surgery and in vivo measurements
Male Wistar rats (250-275 g, n = 16) were obtained from Harlan (Zeist, The Netherlands) and housed under standard conditions at the animal facilities of the University of Groningen. Animals had free access to food and drinking water throughout the study. All animal experiments were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals, and approved by the Committee for Animal Experiments of the University of Groningen. Under general anaesthesia with 3% isoflurane in N 2 O/O 2 (2:1), the rats underwent laparoscopic 5/6 Nx by removal of the right kidney and ligation of two or three branches of the renal artery of the left kidney, leading to infarction of approximately 2/3 of this kidney. Postoperatively, the rats received a subcutaneous injection of diluted buprenorphin (Temgesic ® , 0.01 mg/kg) for analgesic purposes. To achieve maximal therapeutical response, we administered losartan one week prior to 5/6 Nx and therefore, one week before surgery, rats were randomised in two groups: untreated (5/6 Nx, n = 8) and treated with losartan (5/6 Nx + LOS, n = 8). Losartan was dissolved in the drinking water at a dose of 20 mg/kg body weight/day.
Vascular reactivity of small mesenteric resistance arteries
Small third-order branches of the superior mesenteric arteries were separated from the perivascular tissue and transferred to an arteriograph system for pressurised arteries (Living System Instrumentation, Burlington, VT, USA) as described previously. 25 Arterial segments were cannulated on glass micropipettes and the vessel chamber was continuously recirculated with warmed (37°C) and oxygenated (5% CO 2 in O 2 ) Krebs solution with a pH of 7.4. An inverted light microscope attached to a video camera and video dimension analyser was used to continuously register luminal diameter and the arterial wall. Arterial wall thickness was determined in calcium-free EGTA solution at a pressure of 60 mmHg.
Myogenic reactivity of small mesenteric resistance arteries
The intraluminal pressure was set at 60 mmHg, and arteries were allowed to equilibrate for 45 min and were checked for the viability of smooth muscle and endothelium by a single dose of phenylephrine (PE, 3 × 10 -7 mol/l) and acetylcholine (Ach, 3 × 10 -5 mol/l), respectively. Following wash-out, the intraluminal pressure was decreased to 20 mmHg and myogenic reactivity was studied by obtaining active pressurediameter curves over a pressure range of 20-160 mmHg in steps of 20 mmHg. Each pressure step was maintained for 5 min in order to reach the point of stable contractile response. Thereafter, calcium-containing Krebs solution was exchanged for calcium-free Krebs solution supplemented with ethyleneglycol-bis-(b-aminoethylether)tetraacetic acid (EGTA, 2 mmol/l), and passive pressure-diameter curves were obtained over the same 20-160 mmHg pressure range.
Alpha 1 receptor-mediated contractility and endothelium-dependent relaxation of mesenteric arteries
Following the determination of myogenic curves, intraluminal pressure was reset to 60 mmHg, and arteries washed and stabilised for 20 min. Thereafter, dose-response curves for PE were assayed by adding cumulative doses (10 -8 -10 -5 mol/l) to the recirculating bath. Subsequently, after the washing-out period, arteries were pre-constricted with PE (10 -6 mol/l). Endothelium-dependent relaxation was assessed by administering cumulative doses of ACh (10 -9 -10 -5 mol/l) to the recirculating bath in the presence of indomethacin (10 -5 mol/l) and indomethacin + L-NMMA (L-NG-monomethyl arginine, 10 -4 mol/l) to investigate the contribution of NO and EDHF (endothelium-derived hyperpolarisation factor) to endothelium-mediated relaxation.
Involvement of ROS in myogenic reactivity and endothelium-dependent relaxation of small mesenteric resistance arteries
To investigate the involvement of ROS in myogenic reactivity and endothelium-dependent relaxation, on separate arterial segments active pressure-diameter curves and ACh dose-response curves were obtained as mentioned above in the presence of tempol (100 μmol/l) and catalase (500 U/ml).
In vivo
Blood pressure. Systolic blood pressure (SBP) was measured weekly in wakeful, restrained animals by means of the tail-cuff method (IITC Inc., Woodland Hills, CA, USA). Twelve weeks after 5/6 Nx, the experiment was terminated and rats were sacrificed.
Proteinuria. Urinary protein excretion was determined by nephelometry (Dade Behring III, Mannheim, Germany) weekly up to 12 weeks after 5/6 Nx by placing the rats in metabolic cages for 24 h.
Clinical chemistry. Plasma and urine creatinine were measured by means of a photometric assay with the Jaffé method without deproteinisation (DiaSys Diagnostic Systems, Holzheim, Germany), and creatinine clearance was calculated as creatinine clearance = (urine creatinine x urine flow)/(plasma creatinine x body weight).
Renal histology
Paraffin-embedded kidneys were cut in 3 μm sections and stained with periodic acid Schiff (PAS); the incidence of focal glomerulosclerosis (FGS) was microscopically evaluated according to standard procedures as described previously. 26 
Solutions and drugs
Vessel segments were perfused with Krebs solution of the following composition (in mmol/l): NaCl, 120.4; KCl, 5.9; CaCl 2 , 2.5; MgCl 2 , 1.2; NaH 2 PO 4 , 1.2; glucose 11.5; NaHCO 3 , 25.0). Losartan (Cozaar®) was purchased from Merck Sharp & Dohme BV (The Netherlands). All other compounds were purchased from Sigma (St. Louis, MO, USA).
Data analysis
Data are expressed as mean ± SEM; n-values represent the number of rats investigated as well as the number of arteries, since one artery segment per rat was used for the same protocol. To characterise myogenic responsiveness, the following parameters were calculated from the pressurediameter curve of each individual artery.
Myogenic tone, describing the myogenic behaviour of an artery at a given pressure, was expressed as percentage decrease in active diameter from the maximally dilated (passive) diameter determined at the same pressure in calcium-free EGTA solution (i.e. MC (%) = 100 × [(DCafree -DCa)/DCa-free], where D is the diameter in calciumfree (DCa-free) or calcium-containing (DCa) Krebs solution. For every individual artery, the maximal segmental myogenic tone was determined as the maximal value over the studied pressure range. The area under the myogenic tone curve (AUC) was determined (SigmaPlot; SPSS, Inc., Chicago, IL, USA) and expressed in arbitrary units.
Concentration-response curves to ACh were expressed as a percentage of pre-constriction to PE. Concentrationresponse curves to PE were expressed as a percentage of constriction to basal diameter.
Statistical differences for vascular parameters, proteinuria, systolic blood pressure, creatinine, body and organ weights, water intake and urinary output were determined by Student's independent t-test. Differences in myogenic tone curves were tested using LSD post hoc multiple comparisons applied to ANOVA for repeated measures. Differences were considered significant at p<0.05 (two-tailed).
Results
Animals
Following 5/6 Nx, four rats died prematurely because of uraemia. Consequently, 12 rats completed the study and were eligible for the full protocol analysis at termination (5/6 Nx, n = 6; 5/6 Nx + LOS, n = 6). Prior to surgery (week 0), the baseline values of body weight, water intake, urinary output and proteinuria were similar in both experimental groups (Table 1) .
Metabolic parameters
Water intake and urine output were significantly higher in the 5/6 Nx group compared with the 5/6 Nx + LOS group (Table 1 ).
Blood pressure
Tail-cuff blood pressure was similar between groups at the start of the study (week -1), but was significantly lower before 5/6 Nx in the 5/6 Nx + LOS group (week 0) due to the treatment with losartan. Furthermore, SBP in the 5/6 Nx + LOS group was significantly decreased compared with the 5/6 Nx group from week 2 until the end of the study (week 12) ( Figure 1(a) ; Table 1 ).
Renal parameters
Within 12 weeks of 5/6 Nx, animals developed renal failure characterised by increased proteinuria (Figure 1(b) ), increased plasma creatinine, decreased creatinine clearance, higher kidney:body weight ratio and significantly higher focal glomerulosclerosis score in the 5/6 Nx group compared with the 5/6 Nx + LOS group (Table 1) . Thus, losartan effectively counteracted the development of renal damage and decline of renal function in 5/6 Nx rats.
Myogenic constriction
As shown in Figure 2 (a), the passive diameter of the small mesenteric arteries did not differ between the experimental groups over the whole pressure range, suggesting no apparent structural changes hampering the maximal relaxant ability of the investigated arteries. The small mesenteric arteries developed myogenic tone dependent on the intraluminal pressure applied to the vessel. The active diameter was significantly higher in the 5/6 Nx group over the pressure range 100-160 mmHg compared with the 5/6 Nx + LOS group (Figure 2(a) ; Table 2 ). Consequently, MC expressed as a percentage of passive diameter was significantly higher in the 5/6 Nx + LOS group compared with the 5/6 Nx group over a pressure range 60-160 mmHg, reaching a maximal myogenic tone of 32.3 ± 7% and 8.9 ± 4% in the 5/6 Nx + LOS and 5/6 Nx groups, respectively (p < 0.01).
Contractility of mesenteric arteries
In order to investigate whether altered MC is due to the generally altered contractility of vascular smooth muscle, arterial segments were exposed to stepwise increasing doses of PE to construct dose-response curves. There was no significant difference observed between studied groups (AUC (arbitrary units), 104.9 ± 5.5 vs. 109.5 ± 10.7 in the 5/6 Nx and 5/6 Nx + LOS groups, respectively) ( Table 3 ).
Arterial wall thickness
To determine any difference in arterial wall thickness, the arterial walls were measured in segments. As shown in Table  3 , there was no significant difference observed between studied groups (arterial wall thickness, 29.5 ± 4.9 μm vs. 22.1 ± 3.4 μm in the 5/6 Nx and 5/6 Nx + LOS groups, rspectively. week 12 3.08 ± 0.1 3.06 ± 0.2 Wet kidney weight (mg/g body weight)
week 12 5.9 ± 0. 
Involvement of ROS in diminished myogenic response
To investigate the involvement of ROS, vascular segments were incubated with tempol and catalase (TC) in vitro.
Acute treatment with TC did not change the passive diameter of the small mesenteric arteries in either group over the whole pressure range (data not shown). As shown in Figure  2 (c), TC induced a significant increase in the myogenic constriction of arterial segments from untreated 5/6 Nx rats (maximal MC, 8.9 ± 4% in 5/6 Nx vs. 21 ± 4% in 5/6 Nx + TC (p < 0.05)). In contrast, TC induced a modest, nonsignificant increase in the myogenic constriction in the 5/6 Nx + LOS group.
Influence of endothelium on MC and effect of ROS scavengers
To explore how the endothelium involved in the impairment MC we decided to construct relaxation dose-response curves for acetylcholine in the presence or absence of tempol and catalase, measuring the levels of both NO and EDHF (Figure 3 ). The mesenteric arteries isolated from the experimental animals responded to acetylcholine to a variable extent, but there was no significant difference observed between the studied groups in both NO- (Figure 3(a) ) and EDHFmediated levels Figure 3 (c). Even less significant difference was observed in the presence of tempol and catalase in both NO- (Figure 3(b) ) and EDHF-mediated levels (Figure 3(d) ). Endothelium-dependent relaxation characterised by the ACh AUC in the presence of indomethacin was 193.8 ± 31.5 for 5/6 Nx and 195.1 ± 24.5 for 5/6 Nx + LOS. Endothelium-dependent relaxation in the presence of 
Discussion
The results of this study indicate for the first time that chronic treatment with an angiotensin II (AII) antagonist improves the MC of mesenteric arteries of rats following 5/6 Nx and, furthermore, we showed that ROS are acutely involved in this. Vettoretti et al. previously showed that chronic treatment with an ACE-i in the same setting protected mesenteric arteries from loss of MC. 15 We have now shown that blockade of AT 1 receptors with losartan is also effective, confirming the role of AT 1 receptors in the pathogenesis of renal failure-associated loss of myogenic function in mesenteric arteries following 5/6 Nx.
Systolic blood pressure and proteinuria
Treatment with losartan prevented an increase in SBP and proteinuria, which is in accordance with other studies, 27 confirming the damaging effect of AT 1 receptor-mediated AII. There was an increase in SBP in the 5/6 Nx + LOS group at 12 weeks postoperatively compared with that in the 5/6 Nx group, suggesting progression in the development of hypertension despite the administration of losartan. This may be explained by other mechanisms involved in the postoperative pathogenesis, such as activation of the sympathetic nervous system. 28
Renal function and focal glomerulosclerosis
Animals treated with losartan showed improved renal function, as evidenced by improved creatinine clearance denoting hyperfiltration. We also observed a decreased incidence of focal glomerulosclerosis in the rats treated with losartan, which confirms the findings of previous studies. 29, 30 Part of the effect of losartan may have been caused by the lowering of blood pressure to (near) physiological levels. Alternatively, a direct role of AT 1 receptors on filtration, apart from the lowering of blood pressure, may contribute to the preservation of renal function, since chronic AT 1 receptor antagonism also preserves renal function in animal models with normal blood pressure. 31 
Myogenic constriction
The nature of the decreased MC in 5/6 Nx is currently unknown. Previous studies showed a decrease in myogenic response of rat mesenteric artery following 5/6 Nx, and these data suggest that increased blood pressure is not caused by elevated peripheral resistance, but increased blood pressure might be the driving force for the diminished response of mesenteric arteries to pressure. 15 The current study confirmed our previous findings, where 5/6 Nx decreases the MC of mesenteric arteries and RAAS intervention reverses this phenomenon. However, Savage et al. reported increased MC of the femoral artery following 5/6 Nx, 32 which seems to be contradictory to the current results. However, differences between vascular beds and the used model showing no hypertension might explain this difference.
In attempting to explain what alters MC in the 5/6 Nx model, hypertension is one possible factor that comes in to consideration. However, following the induction of myocardial infarction in the rat where no increase in blood pressure occurred, an increased MC in mesenteric arteries was observed, 14, 16 suggesting that hypertension does not seem to play any role in the alteration of MC. However, in an aortic binding model, hypertension was present and the mesenteric arteries showed increased MC (Xu et al., 2007, unpublished data) , and in a SHR rat displaying hypertension, an increased MC was described. 10, 11 Based on these facts, hypertension does not seem to play any primary role in governing MC in mesenteric arteries.
There is a lack of data regarding MC of the mesenteric arteries in the 5/6 Nx model. Several questions arise when trying to explain the decrease in MC in this model. The general concept that hypertension is caused by increased peripheral resistance due to the increased MC of peripheral resistance arteries seems to fail in the case of 5/6 Nx, where MC was found to be diminished. Whether hypertension and/or impaired renal function affect MC remains unclear. With a lowering of blood pressure comes improvement in compromised renal function in 5/6 Nx, and thus it is difficult to distinguish between these two possible causes.
To our knowledge there is currently no available evidence for blood pressure-lowering regimes in 5/6 Nx and their effect on MC of the mesenteric arteries. The same holds true for regimes that might improve renal function without lowering blood pressure. However, further exploration of reduced MC of the mesenteric arteries following 5/6 Nx should focus on distinguishing between these options.
Chronic treatment with ACE-i is beneficial following 5/6 Nx: it decreases blood pressure, improves renal function and protects the mesenteric arteries from loss of MC, confirming the role of the RAAS in renal damage but also revealing its action on peripheral vasculature. 15 It is known that the myogenic response, the exact mechanism of which has, to date, not been fully explored, shares similar pathways (GPCR, PLC, PKC, RhoA/Rho kinase) [33] [34] [35] with vasoconstrictive agents such as noradrenaline, endothelin and AII. These pathways, which are activated during hypertension, have been implicated as strongly potentiating myogenic responses. Indeed, we showed the involvement of activated AT 1 receptors in MC in models of chronic heart failure. 14, 16 Increased myogenic responses following the induction of myocardial infarction were observed, and acute antagonism of AT 1 receptors normalised an excessively increased myogenic response in mesenteric arteries. Conversely, downregulation of certain receptor types or pathways due to sustained activation may theoretically decrease myogenic responses. Chronic treatment with losartan may have preserved AT 1 receptors from downregulation, thereby preserving mesenteric arteries from a lowering of MC caused by 5/6 Nx.
Unfortunately, we were unable to find sufficient information in the literature to support this hypothesis, and further research will be required to explore this possibility. Meggs et al. observed, in the partially nephrectomised uraemic rat, the reduced binding properties of alpha-1 receptors in the mesenteric arteryies, 36 which suggests that a similar process may also occur with AT 1 receptors.
Furthermore, we wanted to investigate whether decreased myogenic contractility occurs through the generally lowered contractile ability of vascular smooth muscle, due to a shifting from the contractile to the proliferative phenotype. Construction of dose-response curves for PE did not show any differences between the studied groups, and even the addition of TC had no effect (data not shown). Based on these results, we conclude that the lowered MC of mesenteric arteries in the 5/6 Nx group was not due to the lower contractility of smooth muscle when compared with the 5/6 Nx + LOS group. Hypertension and/or impaired renal function selectively decrease MC in 5/6 Nx rats, without affecting smooth muscle contractility in the mesenteric arteries.
Hypertension is known to cause arterial remodelling at both the macrovascular and microvascular levels, causing changes in vascular function. In the present study, we did not observe significant differences in arterial wall thickness between the two groups. Moreover, there was no difference observed between passive diameter over the whole pressure range between the groups, which suggests that the factors discussed above could not have affected MC.
Effect of tempol and catalase on MC
Oxidative stress is an important contributor to the development of vascular dysfunction found in various pathological conditions. Several experimental data indicate that increased oxidative stress contributes to hypertension in 5/6 Nx. 20, 21 In the present study, the involvement of oxygen superoxide and hydrogen peroxide in the pathological decrease of MC is suggested by the improved myogenic response of mesenteric arteries following 5/6 Nx by the combination of tempol and catalase. Support from other studies comes from the observation that peroxynitrite, which is formed by the reaction of superoxide with NO, is known to inhibit the myogenic response of rat posterior cerebral arteries, 37 suggesting the direct involvement of ROS products in the inhibition of MC. Nevertheless, studies with SOD knockout mice showed a raised MC in mesenteric arteries from these animals, implicating that increased superoxide production in vascular tissue increases the contractile response of vascular smooth muscle to pressure. 38 These findings suggest that the involvement of oxidative stress in MC is dependent on the specific disease model and/or vascular bed.
It is known that AII triggers the production of ROS via the activation of AT 1 receptors, 39 which contributes to a large extent to the oxidative stress in 5/6 Nx. Based on the fact that the effect of ROS scavenging on MC in our study was much higher in untreated animals compared with those treated with losartan, we conclude that there is a direct involvement of ROS in lowered MC, although the molecular mechanism still needs to be elucidated. However, in untreated 5/6 Nx animals, tempol and catalase did not completely reverse the myogenic response to the level of losartan-treated animals. Therefore, acute ROS production at the time of testing in the organ bath does not seem entirely to govern the lowered myogenic response of mesenteric arteries in the 5/6 Nx model.
Source of ROS in mesenteric arteries
Recently, hydrogen peroxide was been implied as being the source of EDHF. 40 Therefore, one might hypothesise that the presence of hydrogen peroxide in vascular tissue due to increased ROS production following 5/6 Nx might be the cause of the observed lowering of MC. However, we can exclude this hypothesis because there was no difference in EDHF-mediated relaxation in the present study. Moreover, there was no effect of catalase (which breaks down hydrogen peroxide) on vascular relaxation.
The endothelium as a source of ROS affecting MC can also be excluded in the present study. There was no apparent effect of tempol and catalase on relaxation, whereas ROS is largely involved in impairment of the NO pathway.
Moreover, we did not observe changes in endotheliummediated relaxation between the two study groups, nor on the levels of EDHF or NO + EDHF. Another possible source of ROS might be the invasion of the arterial wall by inflammatory cells that are highly capable of ROS production. Although we cannot exclude this possibility, the focus of the current study was to explore vascular function and ROS involvement. Therefore our results suggest that the most likely source of ROS was a vascular smooth muscle layer.
In conclusion, the present study showed that the effect of chronic treatment with the AT 1 receptor blocker losartan on CRF under experimental conditions protects the mesenteric arteries from a lowering of myogenic response. Moreover, we conclude that oxidative stress acutely contributed to this phenomenon.
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